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Abstract Aplysianin-A, an antibacterial glycoprotein in the al- 
bumen gland of the sea hare Aplysia kurodai, inhibited the growth 
of both Gram-positive and Gram-negative bacteria. Aplysianin-A 
cDNA clones were isolated from an albumen gland cDNA library. 
Sequence analysis reveals that aplysianin-A is produced as a 
precursor protein of 556 amino acid residues with a signal peptide 
of 19 amino acid residues and contains 6 potential N-glycosyla- 
tion sites. Aplysianin-A mRNA was expressed tissue-specifically 
in the albumen gland. Homology search reveals that aplysianin-A 
has a 50% overall amino acid sequence homology to achacin, an 
antibacterial glycoprotein of the giant African snail Achatina 
fulica. 
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1. Introduction 
Sea hares belong to the subclass Opisthobranchia of marine 
gastropods. They have only degenerated shells in their mantle 
cavity and expose their naked and soft bodies to the surround- 
ings. However, there is no apparent predator which preferably 
preys on them. These observations have attracted investigators' 
interests. To date, various bioactive compounds uch as toxins 
and antibiotics have been isolated from sea hares, mostly from 
their digestive gland. Most of these compounds are lipophilic 
and low molecular weight compounds derived from their algal 
diets and are discussed in connection with the defense system 
of the sea hares against potential predators and pathogenic 
microorganisms [1 3]. Recently, we have found that the sea 
hares possess potent antibacterial glycoproteins in various tis- 
sues [4-8]. Aplysianin-A is an active factor in the albumen gland 
of the sea hare Aplysia kurodai and consists of four identical 
subunits (85 kDa). It inhibited the growth of Bacilus subtilis and 
lysed murine MM46 tumor cells at low concentrations [9]. It is 
of interest o determine from a comparative biochemical point 
of view whether the antibacterial glycoproteins in the sea hares 
have sequences in common with other antibacterial factors 
present in invertebrates [10 13]. We isolated aplysianin-A 
cDNA from an albumen gland eDNA library. The deduced 
complete amino acid sequence of aplysianin-A showed a 50% 
overall amino acid sequence homology to achacin, an anti- 
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bacterial glycoprotein in the mucus of the giant African snail 
which belongs to the subclass Pulmonata of terrestrial gastro- 
pods. Aplysianin-A inhibited the growth of bacteria whether 
they were Gram-positive or Gram-negative species. Here we 
describe the isolation of aplysianin A cDNA, the deduction of 
the complete amino acid sequence, and the antibacterial ctivity 
against various bacterial species. 
2. Materials and methods 
2. l. ,tnimals 
Sea hares were collected in Akita Prefecture, Japan. Each tissue used 
t\~r the experiments was obtained from a live sea hare. Pooled albumen 
glands from more than 200 individuals were kept at -20°C until use. 
2.2. Preparation of aplysianin-A 
Aplysianin-A was purified from the pooled albumen gland tissue by 
a combination of gel filtration, ion exchange chromatography and 
chromatofocusing as described in the previous report [9]. 
2.3. +4 ntibacterial activity o[ aplysianin-A 
Antibacterial ctivity of the purified aplysianin-A was examined tur- 
bidimetrically according to the previous method [4]. Bacterial species 
tested were Aeromonas almonicida, A. hydrophila, B. subtilis, Escheri- 
ehia coli, Edwardsiella tarda, Pseudomonas fluorescens, Streptococcus 
sp, and Vihrio anguillarum. 
2,4. N-terminal and internal amino acid sequence analysis 
The N-terminal sequence of aplysianin-A was analyzed in Shimazu 
gas-phase sequencer PSQ-I. Aplysianin-A was cleaved with cyanogen 
bromide (CNBr) in 70% formic acid at room temperature for 15 h [14]. 
After dried under vacuum, the residue was applied to SDS-PAGE using 
12% gel. The gel was electroblotted onto a polyvinylidene difluoride 
!PVDF) membrane [15], and a major stained band was analyzed for the 
amino acid sequence. 
2.5. h'olation of aplysianin-A cDNA 
Total RNA was extracted by the gaanidium isothiocyanate method 
from tissues of the sea hare A. kurodai except for the albumen gland, 
and cytoplasmic RNA was prepared from the albumen gland as de- 
scribed [16]. Poly(A) + RNA was purified using Oligotex-dT30 (Takara 
Shuzol. Albumen gland cDNA was synthesized by oligo(dT) priming 
and ligated with EcoRl-digested AMOSSlox (Amersham) or 
pBluescript (Stratagene) after attachment of EeoRI adaptor. A partial 
aplysianin-A eDNA fragment was amplified by PCR from the albumen 
gland cDNA ligated with pBluescript using a 20-mer oligonucleotide 
(SK-20) (5'-CGCTCTAGAACTAGTGGATC-Y) which hybridizes 
with pBluescript DNA at a location similar to SK and a fully degenerate 
20-mer antisense oligonucleotide corresponding to the amino acid se- 
quence from 11 to 17 of aplysianin-A (see Fig. 1). PCR products were 
electrophoresed on 1% agarose gel, transferred to a nylon filter and 
probed with a fully degenerate 14-mer oligonucleotide corresponding 
to the amino acid sequence from 5 to 9 of aplysianin-A (see Fig. 1). An 
approximately 200 bp fragment which hybridized with this 14-mer 
oligonucleotide was gel-purified, subcloned, confirmed its identity to be 
the aplysianin-A cDNA by sequencing and used to screen the albumen 
gland cDNA library constructed with 2MOSSlox DNA. Positive phage 
clones were converted to plasmid subclones by cre-mediated xcision. 
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Single-stranded DNA was prepared, and lhe nucleotide sequence ,,,,as 
determined by the dideoxy method. 
2.6. Northern blot analysis 
1.0/Jg of poly(A) + RNA from several tissues was fractionated by 
electrophoresis on a 1.0% agarose-formaldehyde gel. transferrred to a 
nylon filter, fixed by Stratalinker (Stratagene) and probed with the 
aplysianin-A cDNA under the standard condition [16]. 
3. Results and discussion 
3.1. Antibacterial activity o/aplysianin-A 
Aplysianin-A was purified and tested for its antibacterial 
activity using two Gram-posit ive species, B. subtilis and Strep- 
tococcus sp., and six Gram-negative species, A. salmonicida, 
A. hydrophila, E. coli. E. tarda, P. fluorescens and V. anguillarum. 
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Fig. 1. The nucleotide and deduced amino acid sequence of sea hare aplysianin-A cDNA (pAPLY-A3T). The N-terminal amino acid residue is 
numbered as 1. The amino acid sequences determined by protein sequencing of the mature aplysianin-A and its CNBr-cleavaged fragment are 
underlined. The amino acid sequences used to design the oligonucleolides are doubly underlined. Potential N-glycosylation sites are boxed. 
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Fig. 2. Tissue-specific expression of aplysianin-A mRNA. 1.0 ~g of 
poly(A) + RNA from albumen gland (lane 1), purple gland (lane 2), 
gonad (lane 3), midgut gland (lane 4), ctenidium (lane 5) and body wall 
(lane 6) was fractionated on a 1.0% agarose-formaldehyde gel and 
probed with the aplysianin-A cDNA. The positions of mouse 18S and 
28S rRNA are indicated on the right. 
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Among them, A. salmonicida was most sensitive and the growth 
was inhibited by 50% at a concentration of 1.6 ¢zg protein/ml 
or 5 x 10 9 M. P.f luorescent was most resistant (8 ¢tg protein/ml 
for growth inhibition by 50%). The others were inhibited in the 
range of 2 to 7.4/ag protein/ml. The growth of the bacteria was 
depressed after addition of the aplysianin-A, and the period of 
growth depression depended on the amount of aplysianin-A 
added. After depression, the bacteria recovered their normal 
growth. In addition, there was no apparent decrease in turbid- 
ity (data not shown), suggesting that aplysianin-A has no 
bacteriolytic activity. These facts indicate that aplysianin-A was 
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Fig. 3. Comparison of the amino acid sequences of aplysianin-A and achacin. Identical amino acids are shown in white against black, and conservative 
amino acids are shaded. Gaps introduced in the sequences to optimize the alignment are represented by dashes. Potential N-glycosylation sites are 
indicated by asterisks. Conser,~ati~e amino acids are classified as follows: D and E: H, K and R; S and T; I, L, M and V: and F and Y. 
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not bacteriocidal, but bacteriostatic l ke aplysianin-E, an anti- 
bacterial glycoprotein i  the egg mass of A. kurodai [1,17]. 
3.2. Sequence determination and eDNA cloning of aplysianin-A 
Partial amino acid sequences of aplysianin-A were deter- 
mined using the mature protein and its CNBr fragment, and the 
sequences are shown in Fig. 1. To obtain a partial aplysianin-A 
cDNA fragment, PCR was carried out using albumen gland 
cDNA ligated with pBluescript as a template with SK-20, a 
20-mer oligonucleotide which hybridizes with pBluescript 
DNA near the EcoRI site (see section 2), and a fully degenerate 
20-mer antisense oligonucleotide corresponding to the amino 
acid sequence from 11 to 17 of aplysianin-A (see Fig. 1). PCR 
resulted in production of an approximately 200 bp fragment 
which hybridized with a fully degenerate 14-mer oligonucleo- 
tide corresponding to the amino acid sequence from 5 to 9 of 
aplysianin-A (see Fig. 1). This fragment was isolated, subcloned 
and its sequence was determined. The fragment contained the 
nucleotide sequence coding for the N-terminal amino acid se- 
quence shown in Fig. 1. Using this fragment as a probe, an 
albumen gland cDNA library was screened, and several posi- 
tive hybridizing plaques were obtained and converted to plas- 
mid subclones. The clone with the longest cDNA insert 
(pAPLY-A3T) was selected and sequenced on both strands. 
The nucleotide and deduced amino acid sequence are shown 
in Fig. 1. The cDNA is 2605 bp in length, not including poly(A) 
tail, and contains an open reading frame coding for 556 amino 
acid residues. The N-terminal arginine residue determined by 
sequencing the mature protein is numbered as 1 in Fig. 1. The 
amino acid sequence from 1 to 25 and from 76 to 96 agreed with 
the protein sequence data. The nucleotide sequence fi'om 49 to 
106 codes for 19 amino acid residues rich in hydrophobic amino 
acid residues, which is considered to constitute a signal peptide. 
Aplysianin-A contains 9.8% neutral sugar [9], and there are six 
potential N-glycosylation sites, which could account for the 
sugar content. 
3.3. Tissue-specific expression of aplysianin-A mRNA 
To examine the tissue-specific expression of aplysianin-A 
mRNA, poly(A) ÷ RNA was prepared from albumen gland, 
purple gland, gonad, midgut gland, ctenidium and body wall, 
and Northern hybridization was carried out (Fig. 2). Aply- 
sianin-A mRNA was detected only in the albumen gland, and 
its size was calculated to be approximately 2.5 kb. Thus, aply- 
sianin-A is considered to be produced as a precursor specifi- 
cally in the albumen gland. 
3.4. Homology search 
The deduced amino acid sequence of aplysianin-A has a 
significant overall homology to achacin, an antibacterial 
glycoprotein isolated from the body surface mucus of the giant 
African snail Achatinafuliea [13] (48% identity and 59% similar- 
ity) (Fig. 3). Aplysianin-A and achacin share several features: 
they exist as a multimer composed of four or two identical 
subunits, respectively; they are considered to be produced as 
a precursor protein and secreted; they are glycoproteins, and 
the two potential N-glycosylation sites are located at similar 
amino acid positions when aligned. However, aplysianin-A 
mRNA is expressed in the albumen gland, while achacin 
mRNA is expressed in the collar tissue, not in the albumen 
gland. In addition, although achacin is baeteriocidal [18], aply- 
sianin-A is bacteriostatic, not bacteriocidal. These differences 
are likely to imply their divergent physiological roles and may 
reflect he distinct modes of life as the sea hare is aquatic and 
the snail terrestrial. 
In our screening of the antibacterial glycoproteins among 
marine gastropods, only the members of Aplysiidae in the 
Opisthobranchia were recognized to have similar glycoproteins 
so far [7,8,19]. The present study has revealed that the two 
species of gastropods which are phylogenically close to each 
other but have different modes of life possess similar anti- 
bacterial glycoproteins. The information regarding the distri- 
bution of aplysianins, achacin, and related antibacterial 
glycoproteins would be important for understanding the evolu- 
tion of the defense molecules in gastropods. 
References 
[1] Scheuer, RJ. (1982) Naturwissenschaften 69,528-533. 
[2] Kusumi, T., Uchida, H., Inoue, Y., Ishitsuka, M., Yamamoto, H. 
and Kakisawa, H. (1987) J. Org. Chem. 52, 4597~4600. 
[31 Faulkner, D.J. and Stallard, M.O. (1973) Tetrahedron Lett. 19, 
1645-1648. 
[4] Kamiya, H., Muramoto, K., and Ogata K. (1984) Experientia 40, 
947 ..949. 
[5] Yamazaki, M., Kisugi, J., Kimura, K., Kamiya, H. and Mizuno, 
D. (1985) FEBS Lett. 185, 295~98. 
[6] Yamazaki, M., Kimura, K., Kisugi, J. and Kamiya, H. (1986) 
FEBS Lett. 198, 25-28. 
[7] Kamiya, H., Muramoto, K., Goto, R. and Yamazaki, M. (1988) 
Nippon Suisan Gakkaishi 54, 773-777. 
[8] Kamiya, H., Muramoto, K., Goto, R., Sakai, M., Endo, Y. and 
Yamazaki, M. (1989) Toxicon 27, 1269-1277. 
[9] Kamiya, H., Muramoto, K. and Yamazaki, M. (1986) Experientia 
42. 1065 1067. 
[10] Lehrer, I.R., Ganz, T. and Selsted, E.M. (1991) Cell 64, 229- 
230. 
[11] Morishima, I., Suginaka, Ueno, T. and Hirano, H. (1990) Comp. 
Biochem. Physiol. 95B, 551 554. 
[12] Okada, M. and Natori, S. (1985) J. Biol. Chem. 260, 7174~ 
7177. 
1113] Obara, K., Otsuka-Fuchino, H., Sattayasai, N., Nonomura, Y., 
Tsuchiya, T. and Tamiya, T. (1992) Eur. J. Biochem. 209, 1-6. 
[141 Muramoto, K. and Kamiya, H. (1992) Biochim. Biophys. Acta 
1116, 129 136. 
[15] Muramoto, K. and Kamiya, H. (1990)Anal. Biochem. 189, 223 
230. 
[16] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular 
cloning II: a laboratory manual, Cold Spring Harbor Laboratory, 
Cold Spring Harbor, NY. 
[17] Kisugi, J., Ohye, H. Kamiya, H. and Yamazaki, M. (1989) Chem. 
Pharm. Bull. 37, 3050 3053. 
[18] Otsuka-Fuchino, H., Watanabe, Y., Hirakawa, C., Tamiya, T., 
Matsumoto, J.J. and Tsuchiya, T. (1992) Comp. Biochem. Physiol. 
101C. 607~-613. 
[19] Yamazaki, M., Kisugi, J. and Kamiya, H. (1989) Chem. Pharm. 
Bull. 37, 3343 3346. 
